Scientists are learning more about this leading complication of childbirth. Treatments are improving and doctors can test for ...

The FDA has cleared Elecsys pTau181, the first blood test for use in primary care to help rule out Alzheimer’s disease in ...

Rates of one type of breast cancer — invasive lobular carcinoma — have been rising in the United States more than three times ...

But a new generation of noninvasive tests are emerging that could help accelerate diagnosis and improve management of this ...

I’m a health and fitness editor who reviewed Abbot’s Lingo continuous glucose monitor for months. Here’s why medical experts and I agree the wearable is worth trying out.

While Natera said it will seek FDA approval for Signatera based on data from IMvigor011, the readout from another ctDNA-guided de-escalation study was more nuanced.